Please select the option that best describes you:
Topics:
Radiation Oncology • Gastrointestinal Cancers
Do you use more stringent liver constraints when treating HCC with SBRT in patients who are CP B8/9 or C?
For example, will you lower the prescribed dose to achieve a lower mean liver dose?